Senseonics expects to double global patient base in 2025 - Drug Delivery Business

Retrieved on: 2025-03-03 21:21:19

Tags for this article:

Continuous glucose monitor

Blood glucose monitoring

CGM

BlackBerry Limited

Compagnie Générale Transatlantique

Click the tags to see associated articles and topics

Senseonics expects to double global patient base in 2025 - Drug Delivery Business. View article details on hiswai:

Summary

The article discusses Senseonics' advances in diabetes care through their implantable continuous glucose monitor (CGM), Eversense 365. Tags like 'Continuous glucose monitor' and 'Blood glucose monitoring' align with this focus, while 'BlackBerry Limited' and 'Compagnie Générale Transatlantique' seem unrelated.

Article found on: www.drugdeliverybusiness.com

View Original Article